Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice

Gene Therapy volume 8, pages 13–19 (2001)Cite this article

Abstract

Multiple sclerosis (MS) is an immune-mediated inflammatory disease of the central nervous system (CNS) that might benefit from anti-inflammatory therapies. However, systemic delivery of anti-inflammatory drugs in MS patients has so far been disappointing, mostly due to the limited capacity of these molecules to enter the CNS. We injected into the cisterna magna (i.c.) of Biozzi AB/H mice affected by a relapsing–remitting form of experimental autoimmune encephalomyelitis (EAE), the animal model of MS, a non-replicative herpes simplex virus (HSV) type-1-derived vector containing the interleukin (IL)-4 gene (d120:LacZ:IL-4). CNS delivery of the d120:LacZ:IL-4 vector, after EAE onset, induced the in situ production of IL-4 by CNS-resident cells facing the cerebrospinal fluid (CSF) spaces and reduced by 47% (P < 0.02) the disease-related deaths. compared with mice treated with the control d120:lacz vector, il-4-treated mice also showed a shorter duration of the first eae attack, a longer inter-relapse period, and a reduction in the severity and duration of the first relapse. protection from eae progression in il-4-treated mice was associated with activation of microglia in spinal cord areas where mrna content of the pro-inflammatory chemokines, macrophage chemoattractant protein-1 (mcp-1) and rantes, was reduced and that of the anti-inflammatory cytokine il-4 was increased. finally, cns-infiltrating mononuclear cells from il-4-treated mice produced lower levels of mcp-1 mrna compared with control mice. our results, showing that il-4 gene delivery using hsv-1 vectors induces protection from eae by in situ modulating the cytokine/chemokine-mediated circuits sustaining effector cell functions, indicate that the intrathecal ‘therapeutic’ use of nonreplicative hsv-1-derived vectors containing anti-inflammatory molecules might represent an alternative strategy in inflammatory diseases of the cns.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Steinman L . A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry Proc Natl Acad Sci USA 1996 93: 2253–2256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Martino G, Hartung HP . Immunopathogenesis of multiple sclerosis: the role of T cells Curr Opin Neurol 1999 12: 309–321

    Article  CAS  PubMed  Google Scholar 

  3. Kieseier B et al. Effector pathways in immune mediated central nervous system demyelination Curr Opin Neurol 1999 12: 323–336

    Article  CAS  PubMed  Google Scholar 

  4. Selmaj KW, Raine CS . Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro Ann Neurol 1998 23: 339–346

    Article  Google Scholar 

  5. The IFNB Multiple Sclerosis Study Group . Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 1993 43: 655–661

    Article  Google Scholar 

  6. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group . Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years Neurology 1996 47: 889–894

    Article  Google Scholar 

  7. Calabresi PA et al. Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS Neurology 1998 51: 289–292

    Article  CAS  PubMed  Google Scholar 

  8. The Lenercept Multiple Sclerosis Study Group and University of British Columbia MS/MRI Analysis Group ., TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study Neurology 1999 53: 457–465

    Article  Google Scholar 

  9. Khan OA et al. Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration Neurology 1996 46: 1639–1643

    Article  CAS  PubMed  Google Scholar 

  10. Martino G et al. Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors Gene Therapy 2000 7: 1087–1093

    Article  CAS  PubMed  Google Scholar 

  11. Furlan R et al. Central nervous system delivery of interleukin-4 by a non replicative herpes simplex type I viral vector ameliorates autoimmune demyelination Hum Gene Ther 1998 9: 2605–2617

    Article  CAS  PubMed  Google Scholar 

  12. Mattner F et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3 Eur J Immunol 2000 30: 498–508

    Article  CAS  PubMed  Google Scholar 

  13. Racke MK et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease J Exp Med 1994 180: 1961–1966

    Article  CAS  PubMed  Google Scholar 

  14. Inobe JI, Chen Y, Weiner HL . In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis Ann NY Acad Sci 1996 778: 390–392

    Article  CAS  PubMed  Google Scholar 

  15. Brocke S et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein Nature 1996 379: 343–346

    Article  CAS  PubMed  Google Scholar 

  16. Storch M, Lassmann H . Pathology and pathogenesis of demyelinating diseases Curr Opin Neurol 1997 10: 186–192

    Article  CAS  PubMed  Google Scholar 

  17. Reiseter BS, Miller GT, Happ MP, Kasaian MT . Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid J Neuroimmunol 1998 91: 156–170

    Article  CAS  PubMed  Google Scholar 

  18. Aloisi F, Ria F, Adorini L . Regulation of T-cell responses by CNS antigen-presenting cells: different role for microglia and astrocytes Immunol Today 2000 21: 141–147

    Article  CAS  PubMed  Google Scholar 

  19. Matsukawa A et al. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8 Lab Invest 1998 78: 973–985

    CAS  PubMed  Google Scholar 

  20. Weiss JM, Downie SA, Lyman WD, Berman JW . Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood–brain barrier J Immunol 1998 161: 6896–6903

    CAS  PubMed  Google Scholar 

  21. Korner H et al. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting J Exp Med 1997 186: 1585–1590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Liedtke W et al. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors Ann Neurol 1998 44: 35–46

    Article  CAS  PubMed  Google Scholar 

  23. Suzumura A, Sawada M, Itoh Y, Marunouchi T . Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression J Neuroimmunol 1994 53: 209–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Brodie C, Goldreich N, Haiman T, Kazimirsky G . Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion J Neuroimmunol 1998 81: 20–30

    Article  CAS  PubMed  Google Scholar 

  25. Liu JSH, Amaral TD, Brosnan CF, Lee SC . IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia J Immunol 1998 161: 1989–1996

    CAS  PubMed  Google Scholar 

  26. Serot J, Bene MC, Foliguet B, Faure GC . Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium J Neuroimmunol 2000 105: 115–119

    Article  CAS  PubMed  Google Scholar 

  27. Abbas AK, Murphy KM, Sher A . Functional diversity of helper T lymphocytes Nature 1996 383: 787–793

    Article  CAS  PubMed  Google Scholar 

  28. DeLuca NA, McCarthy AM, Schaffer PA . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate–early regulatory protein ICP4 J Virol 1985 56: 558–570

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Allen SJ et al. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse Cell Immunol 1993 146: 335–350

    Article  CAS  PubMed  Google Scholar 

  30. Furlan R et al. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination J Immunol 1999 163: 2403–2409

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was in part supported by Telethon (Italy), Italian Multiple Sclerosis Society (AISM) and MURST.

Author information

Authors and Affiliations

  1. Department of Neuroscience, Neuroimmunology Unit, DIBIT, San Raffaele Scientific Institute, Milan, Italy

    R Furlan, PL Poliani, A Bergami, F Ruffini & G Martino

  2. Telethon Institute for Gene Therapy (TIGET), San Raffaele Scientific Institute, Milan, Italy

    PC Marconi

  3. Roche Milano Ricerche, Milan, Italy

    L Adorini

  4. Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    JC Glorioso

  5. Multiple Sclerosis Center, San Raffaele Scientific Institute, Milan, Italy

    G Comi & G Martino

Authors
  1. R Furlan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PL Poliani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. PC Marconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Bergami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Ruffini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Adorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. JC Glorioso
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Furlan, R., Poliani, P., Marconi, P. et al. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther 8, 13–19 (2001). https://doi.org/10.1038/sj.gt.3301357

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301357

Keywords

This article is cited by

Search

Advanced search

Quick links